Coronavirus: Pfizer, BioNTech apply for EU approval of vaccine
By AFP
05 December 2020 |
4:04 pm
Pfizer and BioNTech have lodged their COVID-19 vaccine with the European Medicines Agency for conditional approval. The companies have already taken similar steps in the US and UK.
Related
Related
25 Jun 2021
The US Centers for Disease Control and prevention have confirmed that myocarditis and pericarditis can occur after mRNA vaccination in young people. But the cases are rare. Medical experts still recommend the shots.
13 Jul 2021
BioNTech and Pfizer said an extra dose of their jab could boost immunity against the coronavirus delta variant. South Korea raised pandemic restrictions as cases hit the "maximum crisis level." Follow DW for the latest.
23 Jul 2021
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.
24 Jul 2021
Researchers say two shots of either BioNTech-Pfizer or AstraZeneca vaccines are highly effective against variants. Elsewhere, China has declined to follow an investigation into the virus's origins. Follow DW for more.
27 Jul 2021
After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.
3 Aug 2021
Vaccines from both drugmakers have been approved in the EU for children from 12 to 17 years of age. Elsewhere, Australia continues its battle against the delta variant. Follow DW for the latest.
20 Sep 2021
The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.
2 Oct 2021
The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.
2 Oct 2021
The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.
6 Oct 2021
While the European Medicines Agency approved a third dose for people over 18-years-old, the agency said it was up to member states to decide whether to use them.
25 Oct 2021
BioNTech and Pfizer and said their vaccine is highly effective among children in the 5-11-year age group. Follow DW for the latest.
14 Nov 2021
Younger people have a higher risk of heart inflammation with a Moderna shot, the country's vaccine advisory committee has said. It also advises on the BioNTech-Pfizer vaccine to all pregnant women.
Latest
43 mins ago
At COP28 in Dubai, German Chancellor Olaf Scholz called for a phase out of fossil fuels, the US announced $3 billion in new climate funding and France pushed for nuclear energy as a way to reduce emissions.
43 mins ago
South Korea has been ramping up its surveillance capabilities in order to gain a strategic edge over North Korea. The move comes after North Korea launched a satellite of its own in violation of UN resolutions.
1 hour ago
Early drafts of the COP28 agreement refer to the "phasedown/out" of fossil fuels, which are responsible for most climate emissions. The final wording will likely be disputed. What's the difference — and does it matter?
1 hour ago
Britain and Rwanda have inked a new treaty aimed at rescuing failed plans for the UK to deport asylum-seekers. A top court ruling had blocked the policy, saying it violated human rights laws enshrined in UK legislation.
4 hours ago
After the military burned down their village, one community describe their efforts to survive in a diplaced person's camp on the fringes of the jungle in the Sagaing region.
4 hours ago
Junta-led Mali, Burkina Faso, and Niger have ditched the G5 anti-jihadist force. Experts say their intended confederation to tackle Islamist insurgents in the Sahel is bound to fail unless they mend ties with ECOWAS.
×

Get the latest news delivered straight to your inbox every day of the week. Stay informed with the Guardian’s leading coverage of Nigerian and world news, business, technology and sports.